Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![AponiaAnalytics Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1816152863069925376.png) aponia_analytics [@AponiaAnalytics](/creator/twitter/AponiaAnalytics) on x 4965 followers
Created: 2025-07-20 14:22:42 UTC

🦉 Weight Loss That Lasts: Reviewing the Long-Term Impact of GLP-1 Receptor Agonists

All six RCTs used treatment durations ≥40 weeks. GLP-1 RAs showed sustained weight loss and metabolic improvements across diabetic and non-diabetic cohorts. #GLP1 #RCT $NVO $LLY


XX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1946938823163728174/c:line.svg)

**Related Topics**
[$lly](/topic/$lly)
[ras](/topic/ras)
[longterm](/topic/longterm)
[weight loss](/topic/weight-loss)
[$nvo](/topic/$nvo)
[stocks healthcare](/topic/stocks-healthcare)
[eli lilly](/topic/eli-lilly)

[Post Link](https://x.com/AponiaAnalytics/status/1946938823163728174)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

AponiaAnalytics Avatar aponia_analytics @AponiaAnalytics on x 4965 followers Created: 2025-07-20 14:22:42 UTC

🦉 Weight Loss That Lasts: Reviewing the Long-Term Impact of GLP-1 Receptor Agonists

All six RCTs used treatment durations ≥40 weeks. GLP-1 RAs showed sustained weight loss and metabolic improvements across diabetic and non-diabetic cohorts. #GLP1 #RCT $NVO $LLY

XX engagements

Engagements Line Chart

Related Topics $lly ras longterm weight loss $nvo stocks healthcare eli lilly

Post Link

post/tweet::1946938823163728174
/post/tweet::1946938823163728174